Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)
NCT01512901 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL
Last updated 2014-07-21
Summary
This study will evaluate the efficacy and safety of Betamethasone Microsphere (DE-102) for macular edema following branch retinal vein occlusion
Conditions
- Macular Edema Following Branch Retinal Vein Occlusion
Interventions
- DRUG
-
Betamethasone Microsphere (DE-102) Low Dose
- DRUG
-
Betamethasone Microsphere (DE-102) High Dose
- DRUG
-
Sham
Sponsors & Collaborators
-
Santen Pharmaceutical Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Japan
- South Korea
Study Locations
More Related Trials
-
Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
NCT04601688 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion
NCT04812977 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein Occlusion
NCT01044329 ·Status: UNKNOWN ·Phase: PHASE2
-
Major and Macular Branched Retinal Venous Occlusion
NCT01219205 ·Status: COMPLETED ·Phase: NA
-
Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial
NCT00370422 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular Oedema
NCT01095809 ·Status: TERMINATED ·Phase: PHASE3
-
A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders
NCT04516278 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Therapy for Neovascular Age Related Macular Degeneration
NCT00447031 ·Status: WITHDRAWN ·Phase: NA
-
Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia
NCT01716026 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial
NCT00370851 ·Status: COMPLETED ·Phase: PHASE3
-
Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema
NCT02985619 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia
NCT00967850 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion
NCT00370266 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients
NCT06882551 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy
NCT04511715 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema
NCT00370669 ·Status: UNKNOWN ·Phase: PHASE3
-
Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
NCT04601701 ·Status: UNKNOWN ·Phase: NA
-
Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)
NCT00997191 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab for Refractory Diabetic Macular Edema (IBEME Study)
NCT00468351 ·Status: UNKNOWN ·Phase: PHASE1
-
Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic Retinopathy
NCT01422018 ·Status: UNKNOWN ·Phase: NA
-
Short-term Effects of Intravitreal Bevacizumab and Triamcinolone in Patients With Diabetic Macular Edema
NCT00563940 ·Status: COMPLETED
-
A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders
NCT05112861 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Navigated Laser In Branch Retinal Vein Occlusion Study
NCT03651011 ·Status: COMPLETED ·Phase: NA
-
Comparison of Therapeutic Effects Between Intravitreal Injection of Bevacizumab With Intravitreal Injection of Bevacizumab and Targeted Laser Photocoagulation of Non Perfused Areas of Retina in Patients With Acute Retinal Vein Occlusion
NCT03353324 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema
NCT02663141 ·Status: COMPLETED ·Phase: PHASE2